Michelle Obama has made her first Instagram appearance since swirling divorce rumors hit her and her husband, former President Barack Obama. The former first lady posted a video announcing her ...
All the latest on former First Lady of the United States, Michelle Obama. The attorney, author and wife of Barack Obama made history as the first African-American First Lady of the United States ...
New Insights Into the Biology and Risk Factors of Childhood Obesity Jan. 15, 2025 — A cutting-edge molecular approach provides a detailed picture of the biological pathways associated with ...
Chapman says her relationship with Penguin Random House (PRH) started in 2018 when Michelle Obama was gearing up to release Becoming. “She wanted to make sure the roll out centered Black women ...
Republican state legislators across the country are filing a flurry of bills to advance the “Make America Healthy Again” ...
Diabetes and Obesity Drugs Fuel Eli Lilly Profit in the Final Quarter of 2024 Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments ...
Childhood obesity has been on the rise in the United States for over a decade, and, according to the American Heart Association (AHA), approximately one in three children and teenagers lives with ...
Obesity rates in Britain are soaring with nearly a quarter of adults now classed as clinically obese. Despite Government warnings that we are turning into a nation of couch potatoes and risking ...
Michelle Singletary writes the nationally syndicated personal finance column “The Color of Money,” which appears in The Washington Post on Wednesdays and Sundays. If you have a personal ...
The Trump administration has appealed a judge’s ruling finding the White House had not fully followed his order to unfreeze federal spending and must release billions of dollars in funding The ...
When a Harvard MBA No Longer Guarantees a Job, Seek a Different Sort of Education Stand Athwart the Progressive Leviathan Pro-Life Means Pro-Baby and Pro-Mother, in Tennessee and Elsewhere History ...
Within Novo Nordisk's comprehensive business update to investors, attention latched onto early data for an oral obesity therapy that outperformed the company’s big-selling GLP-1 agonist Wegovy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results